Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KB2115 in Primary Hypercholesterolemia (Phase II, 12-week, Finland)
2006-003191-35Phase 2Completed
- Sponsor
- Karo Healthcare AB
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of eprotirome in hypercholesterolemia (3 arms), sponsored by Karo Healthcare AB. Primary endpoint: Change in LDL-cholesterol from baseline to Week 12. Started Sep 2006; status: completed.
02
Drugs
eprotirome
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on 2006-003191-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003191-35.